 Methylenedioxypyrovalerone

Methylenedioxypyrovalerone (MDPV) is a stimulant of the cathinone class which acts as a Norepinephrine–dopamine reuptake inhibitor (NDRI).It was first developed in the 1960s by a team at Boehringer Ingelheim.